Access to this article is available to valid users

Register: If you do not have one already, register for a free account.

Article Abstract

Mr. A, a 32-year-old patient with a 10-year
history of schizophrenia, has been clinically stable without any readmissions
into inpatient care while taking haloperidol for the past 5 years. According to
recent neuropsychological testing results, Mr. A has considerable impairments
in episodic memory, executive functions, vigilance, and verbal skills, which
may be associated with his reduced ability to function in society. What
pharmacotherapeutic intervention might you employ to try to improve Mr. A's
cognitive impairments? This interactive Case and Comment allows you to explore
various treatment options to enhance Mr. A's cognitive deficits and improve his
functional outcome